RVTY – Revvity Inc

RVTY — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.92

Margin Of Safety %

Put/Call OI Ratio

0.89

EPS Next Q Diff

-3.66

EPS Last/This Y

3.17

EPS This/Next Y

0.57

Price

93.98

Target Price

113

Analyst Recom

2.28

Performance Q

-2.14

Upside

-50.6%

Beta

1.08

Ticker: RVTY

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-15	RVTY	92.92	6.06	0.08	11376
2026-04-16	RVTY	89.36	5.87	0.50	11430
2026-04-17	RVTY	93.97	6.52	0.76	11267
2026-04-20	RVTY	93.08	3.17	0.14	4529
2026-04-21	RVTY	94.26	3.16	0.03	4533
2026-04-22	RVTY	94.38	3.11	5.00	4549
2026-04-23	RVTY	87.15	3.13	0.42	4599
2026-04-24	RVTY	86.76	1.11	36.75	6154
2026-04-27	RVTY	86.83	1.14	2.00	6239
2026-04-28	RVTY	85.21	1.14	0.01	6247
2026-04-29	RVTY	82.26	0.92	0.43	6930
2026-04-30	RVTY	86.67	0.90	0.93	6983
2026-05-01	RVTY	86.68	0.91	1.00	7000
2026-05-04	RVTY	86.59	0.91	1.37	7005
2026-05-05	RVTY	92.24	0.91	0.91	8442
2026-05-06	RVTY	99.03	0.91	0.32	8445
2026-05-07	RVTY	98.84	0.90	0.02	8472
2026-05-08	RVTY	101.04	0.87	0.48	8795
2026-05-11	RVTY	99.01	0.88	0.94	8837
2026-05-12	RVTY	99.3	0.88	2.28	8854
2026-05-13	RVTY	95.03	0.88	5.00	8861
2026-05-14	RVTY	96.42	0.88	3.43	8877
2026-05-15	RVTY	94.01	0.89	999.99	8886
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-15	RVTY	92.91	0.6	150.8	5.40
2026-04-16	RVTY	89.49	0.6	138.3	5.40
2026-04-17	RVTY	93.97	0.6	173.9	5.40
2026-04-20	RVTY	93.06	0.6	149.5	5.40
2026-04-21	RVTY	94.25	0.6	159.0	5.40
2026-04-22	RVTY	94.26	0.6	153.5	5.40
2026-04-23	RVTY	87.18	0.6	122.2	5.40
2026-04-24	RVTY	86.77	0.5	151.7	5.40
2026-04-27	RVTY	86.84	0.5	153.8	5.40
2026-04-28	RVTY	85.19	0.5	145.9	5.40
2026-04-29	RVTY	82.26	0.5	139.6	5.40
2026-04-30	RVTY	86.63	0.5	175.0	5.40
2026-05-01	RVTY	86.68	0.5	153.8	5.40
2026-05-04	RVTY	86.60	0.5	153.1	5.40
2026-05-05	RVTY	92.26	0.5	180.7	5.40
2026-05-06	RVTY	99.03	0.5	183.5	5.40
2026-05-07	RVTY	98.82	0.5	151.9	5.40
2026-05-08	RVTY	101.03	4.2	162.3	5.38
2026-05-11	RVTY	98.96	4.2	144.6	5.38
2026-05-12	RVTY	99.32	3.0	154.6	5.24
2026-05-13	RVTY	95.06	3.0	135.6	5.24
2026-05-14	RVTY	96.39	3.0	160.2	5.24
2026-05-15	RVTY	93.98	3.0	143.7	5.24
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-15	RVTY	-8.29	-2.33	7.41
2026-04-17	RVTY	-8.29	-2.33	7.41
2026-04-20	RVTY	-8.29	-2.08	7.41
2026-04-21	RVTY	-8.29	-2.08	7.41
2026-04-22	RVTY	-8.30	-2.08	7.41
2026-04-23	RVTY	-7.98	-2.08	7.41
2026-04-24	RVTY	-7.98	-2.08	7.41
2026-04-27	RVTY	-7.98	-2.18	7.53
2026-04-28	RVTY	-7.98	-2.18	7.53
2026-04-29	RVTY	-7.98	-2.18	7.53
2026-04-30	RVTY	-7.98	-2.18	7.53
2026-05-01	RVTY	-7.98	-2.18	7.53
2026-05-04	RVTY	-7.98	-2.34	7.53
2026-05-05	RVTY	-7.98	-2.34	7.53
2026-05-06	RVTY	-7.98	-2.34	7.53
2026-05-07	RVTY	-7.98	-2.34	7.53
2026-05-08	RVTY	-7.98	-2.34	7.53
2026-05-11	RVTY	-7.98	-2.98	7.53
2026-05-12	RVTY	-7.98	-2.98	7.90
2026-05-13	RVTY	-7.98	-2.98	7.90
2026-05-14	RVTY	-7.98	-2.98	7.90
2026-05-15	RVTY	-8.00	-2.98	7.92
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

4.97

Avg. EPS Est. Current Quarter

1.22

Avg. EPS Est. Next Quarter

1.31

Insider Transactions

-8

Institutional Transactions

-2.98

Beta

1.08

Average Sales Estimate Current Quarter

704

Average Sales Estimate Next Quarter

689

Fair Value

107.81

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

53.7

Max Drawdown 5-Year %

-59

Target Price

113

P/E

44.54

Forward P/E

16.14

PEG

1.92

P/S

3.61

P/B

1.46

P/Free Cash Flow

21.28

EPS

2.11

Average EPS Est. Cur. Y

5.24

EPS Next Y. (Est.)

5.81

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.31

Relative Volume

0.99

Return on Equity vs Sector %

-23.6

Return on Equity vs Industry %

-7.6

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.16

EBIT Estimation

143.7

◆ RVTY Healthcare

$93.97

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

5/25

Volume

4/15

Valuation

20/20

TP/AR

1/10

Options

3/10

RSI

51.9

Range 1M

61.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

11/30

Estimates

4/20

Inst/Vol

2/15

Options

4/10

EPS Yr

3.8%

EPS NY

10.8%

52W%

35.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +26.5% upside

Quality

7/30

Valuation

14/30

Growth

7/25

Stability

7/10

LT Trend

2/5

Upside

+26.5%

Quality

MoS

15%

Revvity, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 11000

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

RVTY

Latest News

—

Caricamento notizie per RVTY…

stock quote shares RVTY – Revvity Inc Stock Price stock today

news today RVTY – Revvity Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch RVTY – Revvity Inc yahoo finance google finance

stock history RVTY – Revvity Inc invest stock market

stock prices RVTY premarket after hours

ticker RVTY fair value insiders trading

XGN – Exagen Inc.

XGN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.43

Margin Of Safety %

Put/Call OI Ratio

0.03

EPS Next Q Diff

EPS Last/This Y

0.17

EPS This/Next Y

0.31

Price

3.63

Target Price

8.67

Analyst Recom

Performance Q

10.98

Upside

-946.2%

Beta

1.87

Ticker: XGN

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-15	XGN	3.08	0.02	0.00	865
2026-04-16	XGN	3.06	0.02	0.00	865
2026-04-17	XGN	3.1	0.02	0.00	865
2026-04-20	XGN	3.01	0.02	0.00	865
2026-04-21	XGN	2.92	0.02	0.00	865
2026-04-22	XGN	2.89	0.02	0.00	865
2026-04-23	XGN	2.68	0.02	0.00	865
2026-04-24	XGN	2.71	0.01	0.00	376
2026-04-27	XGN	2.74	0.01	1.00	377
2026-04-28	XGN	2.74	0.02	0.00	379
2026-04-29	XGN	2.78	0.02	0.00	379
2026-04-30	XGN	2.91	0.02	0.10	381
2026-05-01	XGN	3.05	0.02	0.10	381
2026-05-04	XGN	3.11	0.02	0.00	382
2026-05-05	XGN	3.08	0.02	0.00	382
2026-05-06	XGN	3.09	0.02	0.00	382
2026-05-07	XGN	2.93	0.02	0.00	382
2026-05-08	XGN	2.95	0.02	0.00	384
2026-05-11	XGN	3.99	0.02	0.06	411
2026-05-12	XGN	3.7	0.02	0.00	471
2026-05-13	XGN	3.46	0.02	0.00	474
2026-05-14	XGN	3.84	0.04	0.00	482
2026-05-15	XGN	3.65	0.03	0.00	504
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-15	XGN	3.08	-25.0	3.5	-0.80
2026-04-16	XGN	3.06	-25.0	3.9	-0.80
2026-04-17	XGN	3.10	-25.0	3.7	-0.76
2026-04-20	XGN	2.99	-25.0	4.1	-0.76
2026-04-21	XGN	2.93	-25.0	4.1	-0.76
2026-04-22	XGN	2.88	-25.0	4.0	-0.76
2026-04-23	XGN	2.68	-25.0	4.7	-0.76
2026-04-24	XGN	2.70	-25.0	3.6	-0.76
2026-04-27	XGN	2.73	-25.0	3.5	-0.76
2026-04-28	XGN	2.75	-25.0	3.8	-0.76
2026-04-29	XGN	2.78	-25.0	3.6	-0.76
2026-04-30	XGN	2.90	-25.0	3.2	-0.76
2026-05-01	XGN	3.06	-25.0	3.0	-0.76
2026-05-04	XGN	3.10	-25.0	3.6	-0.76
2026-05-05	XGN	3.08	-25.0	4.0	-0.76
2026-05-06	XGN	3.09	-25.0	3.8	-0.76
2026-05-07	XGN	2.94	-25.0	4.4	-0.76
2026-05-08	XGN	2.94	-25.0	3.8	-0.76
2026-05-11	XGN	3.99	-25.0	-0.9	-0.76
2026-05-12	XGN	3.70	-25.0	4.7	-0.76
2026-05-13	XGN	3.47	-25.0	4.1	-0.76
2026-05-14	XGN	3.85	-25.0	0.1	-0.76
2026-05-15	XGN	3.63	-25.0	2.2	-0.76
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-15	XGN	-0.69	8.93	9.99
2026-04-17	XGN	-0.69	8.93	9.99
2026-04-20	XGN	-0.69	8.93	9.99
2026-04-21	XGN	-0.33	8.93	9.99
2026-04-22	XGN	-0.33	8.93	9.99
2026-04-23	XGN	-0.33	8.93	9.80
2026-04-24	XGN	-0.34	8.93	9.80
2026-04-27	XGN	-0.34	6.47	4.66
2026-04-28	XGN	-0.34	6.47	4.66
2026-04-29	XGN	-0.34	6.47	4.66
2026-04-30	XGN	-0.34	6.47	4.66
2026-05-01	XGN	-0.34	6.47	4.66
2026-05-04	XGN	-0.34	6.60	4.66
2026-05-05	XGN	-0.34	6.60	4.66
2026-05-06	XGN	-0.34	6.60	4.66
2026-05-07	XGN	-0.34	6.60	4.66
2026-05-08	XGN	-0.34	6.60	4.66
2026-05-11	XGN	-0.34	5.40	4.48
2026-05-12	XGN	-0.37	5.40	4.45
2026-05-13	XGN	-0.37	5.40	4.45
2026-05-14	XGN	-0.37	5.40	4.43
2026-05-15	XGN	-0.37	5.40	4.43
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.17

Avg. EPS Est. Current Quarter

-0.2

Avg. EPS Est. Next Quarter

-0.17

Insider Transactions

-0.37

Institutional Transactions

5.4

Beta

1.87

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

79.4

Max Drawdown 5-Year %

-92

Target Price

8.67

P/E

Forward P/E

PEG

P/S

1.29

P/B

6.08

P/Free Cash Flow

EPS

-0.88

Average EPS Est. Cur. Y

-0.76

EPS Next Y. (Est.)

-0.45

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-29.49

Relative Volume

0.78

Return on Equity vs Sector %

-166.7

Return on Equity vs Industry %

-150.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

2.2

◆ XGN Healthcare

$3.64

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

8/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

59.6

Range 1M

70.2%

Sup Dist

3.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

25/30

Estimates

1/20

Inst/Vol

7/15

Options

8/10

EPS Yr

26.7%

EPS NY

27.7%

52W%

11.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +138.2% upside

Quality

5/30

Valuation

16/30

Growth

19/25

Stability

4/10

LT Trend

2/5

Upside

+138.2%

Quality

Exagen Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 216

Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of complex rheumatic, and autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company's lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus platform, a cornerstone of the SLE assessment that begins by quantifying the level of CB-CAPs biomarkers (EC4d and BC4d) in the patient's blood; and AVISE APS that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE Anti-Histone, a test for autoantibodies to histone proteins; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP, a biomarker-driven RA prognostic test. Further, the company offers AVISE SLE Monitor, a blood test that employs CB-CAPs technology; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop T-Cell biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.

XGN

Latest News

—

Caricamento notizie per XGN…

stock quote shares XGN – Exagen Inc. Stock Price stock today

news today XGN – Exagen Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch XGN – Exagen Inc. yahoo finance google finance

stock history XGN – Exagen Inc. invest stock market

stock prices XGN premarket after hours

ticker XGN fair value insiders trading

VCYT – Veracyte Inc.

VCYT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

8.82

Margin Of Safety %

-18

Put/Call OI Ratio

0.18

EPS Next Q Diff

-0.09

EPS Last/This Y

0.99

EPS This/Next Y

0.02

Price

38.47

Target Price

47.4

Analyst Recom

1.55

Performance Q

7.58

Upside

-63.2%

Beta

1.9

Ticker: VCYT

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-15	VCYT	34.01	0.16	5.00	2791
2026-04-16	VCYT	33.03	0.17	0.18	2820
2026-04-17	VCYT	33.82	0.17	0.27	2820
2026-04-20	VCYT	33.43	0.35	0.21	1347
2026-04-21	VCYT	33.52	0.33	0.17	1442
2026-04-22	VCYT	33.75	0.33	0.08	1450
2026-04-23	VCYT	33.17	0.31	0.00	1523
2026-04-24	VCYT	34.34	0.31	0.05	1545
2026-04-27	VCYT	33.85	0.30	0.04	1559
2026-04-28	VCYT	33.45	0.29	0.33	1609
2026-04-29	VCYT	31.79	0.23	0.20	2016
2026-04-30	VCYT	32.94	0.22	0.43	2071
2026-05-01	VCYT	33.07	0.24	0.45	2091
2026-05-04	VCYT	33.46	0.24	0.51	2123
2026-05-05	VCYT	32.98	0.25	0.93	2206
2026-05-06	VCYT	41.24	0.27	0.16	2258
2026-05-07	VCYT	40.76	0.16	1.91	3603
2026-05-08	VCYT	40.44	0.18	0.62	3633
2026-05-11	VCYT	39.7	0.18	0.00	3644
2026-05-12	VCYT	39.53	0.18	0.09	3659
2026-05-13	VCYT	38.26	0.18	0.00	3655
2026-05-14	VCYT	38.87	0.18	0.00	3658
2026-05-15	VCYT	38.48	0.18	0.00	3658
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-15	VCYT	34.01	6.9	10.0	1.65
2026-04-16	VCYT	33.02	6.9	8.1	1.65
2026-04-17	VCYT	33.79	6.9	12.9	1.65
2026-04-20	VCYT	33.43	6.9	9.6	1.65
2026-04-21	VCYT	33.51	6.9	10.9	1.65
2026-04-22	VCYT	33.75	6.9	11.4	1.65
2026-04-23	VCYT	33.15	6.3	9.1	1.65
2026-04-24	VCYT	34.34	6.3	14.0	1.65
2026-04-27	VCYT	33.87	6.3	9.6	1.65
2026-04-28	VCYT	33.46	6.3	9.7	1.65
2026-04-29	VCYT	31.78	6.3	6.3	1.65
2026-04-30	VCYT	32.92	6.3	14.1	1.65
2026-05-01	VCYT	33.08	7.5	11.2	1.65
2026-05-04	VCYT	33.46	7.5	11.9	1.65
2026-05-05	VCYT	32.98	7.5	9.5	1.65
2026-05-06	VCYT	41.22	7.5	33.7	1.65
2026-05-07	VCYT	40.75	-4.7	-8.1	1.65
2026-05-08	VCYT	40.44	-4.7	-27.6	1.65
2026-05-11	VCYT	39.69	-1.0	-28.5	1.82
2026-05-12	VCYT	39.55	-1.5	-8.5	1.83
2026-05-13	VCYT	38.26	-1.5	-11.2	1.83
2026-05-14	VCYT	38.89	-1.5	-6.6	1.83
2026-05-15	VCYT	38.47	-1.5	-9.2	1.83
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-15	VCYT	-12.03	-3.12	8.14
2026-04-16	VCYT	-12.03	-3.12	8.14
2026-04-17	VCYT	-12.03	-3.12	8.14
2026-04-20	VCYT	-12.03	-3.01	8.14
2026-04-21	VCYT	-12.03	-3.01	8.14
2026-04-22	VCYT	-12.03	-3.01	8.14
2026-04-23	VCYT	-12.03	-3.01	8.15
2026-04-24	VCYT	-11.04	-3.01	8.15
2026-04-27	VCYT	-11.04	-3.16	8.32
2026-04-28	VCYT	-11.04	-3.16	8.32
2026-04-29	VCYT	-11.04	-3.16	8.32
2026-04-30	VCYT	-11.00	-3.16	8.32
2026-05-01	VCYT	-11.00	-3.16	8.28
2026-05-04	VCYT	-11.00	-3.06	8.28
2026-05-05	VCYT	-11.00	-3.06	8.28
2026-05-06	VCYT	-11.00	-3.06	8.28
2026-05-07	VCYT	-11.00	-3.06	8.28
2026-05-08	VCYT	-8.15	-3.06	8.28
2026-05-11	VCYT	-8.60	0.45	8.28
2026-05-12	VCYT	-8.60	0.45	8.82
2026-05-13	VCYT	-8.11	0.45	8.82
2026-05-14	VCYT	-8.11	0.45	8.82
2026-05-15	VCYT	-8.11	0.45	8.82
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

0.52

Avg. EPS Est. Current Quarter

0.43

Avg. EPS Est. Next Quarter

0.43

Insider Transactions

-8.11

Institutional Transactions

0.45

Beta

1.9

Average Sales Estimate Current Quarter

144

Average Sales Estimate Next Quarter

148

Fair Value

31.62

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

28.9

Max Drawdown 5-Year %

-71.5

Target Price

47.4

P/E

35.42

Forward P/E

20.2

PEG

4.96

P/S

5.67

P/B

2.28

P/Free Cash Flow

19.77

EPS

1.09

Average EPS Est. Cur. Y

1.83

EPS Next Y. (Est.)

1.85

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.25

Relative Volume

Return on Equity vs Sector %

-20.4

Return on Equity vs Industry %

-4.4

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.18

EBIT Estimation

-9.2

◆ VCYT Healthcare

$38.48

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

10/25

Volume

1/15

Valuation

13/20

TP/AR

1/10

Options

6/10

RSI

59.8

Range 1M

69.1%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

16/30

Estimates

5/20

Inst/Vol

5/15

Options

8/10

EPS Yr

2.5%

EPS NY

4.5%

52W%

57.3%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -19.5% upside

Quality

16/30

Valuation

1/30

Growth

11/25

Stability

9/10

LT Trend

1/5

Upside

-19.5%

Quality

MoS

-18%

Veracyte, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 755

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

VCYT

Latest News

—

Caricamento notizie per VCYT…

stock quote shares VCYT – Veracyte Inc. Stock Price stock today

news today VCYT – Veracyte Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VCYT – Veracyte Inc. yahoo finance google finance

stock history VCYT – Veracyte Inc. invest stock market

stock prices VCYT premarket after hours

ticker VCYT fair value insiders trading

CSTL – Castle Biosciences Inc.

CSTL — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.82

Margin Of Safety %

Put/Call OI Ratio

0.53

EPS Next Q Diff

0.22

EPS Last/This Y

-0.44

EPS This/Next Y

0.47

Price

19.16

Target Price

45.88

Analyst Recom

1.12

Performance Q

-42.29

Upside

-178.7%

Beta

1.04

Ticker: CSTL

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-15	CSTL	24.66	0.18	999.99	1471
2026-04-16	CSTL	24.58	0.18	1.00	1471
2026-04-17	CSTL	25.06	0.11	0.00	1390
2026-04-20	CSTL	25.17	0.30	999.99	345
2026-04-21	CSTL	24.58	0.31	0.00	346
2026-04-22	CSTL	25.12	0.31	0.00	346
2026-04-23	CSTL	23.72	0.30	0.00	347
2026-04-24	CSTL	24.5	0.26	0.17	388
2026-04-27	CSTL	25	0.26	0.00	395
2026-04-28	CSTL	24.71	0.25	999.99	411
2026-04-29	CSTL	24.3	0.25	0.00	412
2026-04-30	CSTL	24.47	0.25	0.00	413
2026-05-01	CSTL	24.83	0.25	999.99	414
2026-05-04	CSTL	25.52	0.25	0.00	415
2026-05-05	CSTL	24.62	0.26	0.36	411
2026-05-06	CSTL	24.73	0.26	45.18	423
2026-05-07	CSTL	19.25	2.42	16.79	1197
2026-05-08	CSTL	19.78	0.70	1.00	664
2026-05-11	CSTL	19.05	0.70	0.00	666
2026-05-12	CSTL	18.63	0.55	0.67	609
2026-05-13	CSTL	18.13	0.54	0.00	611
2026-05-14	CSTL	18.87	0.53	0.67	622
2026-05-15	CSTL	19.12	0.53	0.30	626
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-15	CSTL	24.66	45.7	-7.2	-1.18
2026-04-16	CSTL	24.58	45.7	-6.4	-1.18
2026-04-17	CSTL	25.06	45.7	-7.6	-1.18
2026-04-20	CSTL	25.19	45.7	-6.7	-1.17
2026-04-21	CSTL	24.55	45.7	-5.1	-1.17
2026-04-22	CSTL	25.12	45.7	-7.8	-1.17
2026-04-23	CSTL	23.74	45.7	-3.5	-1.17
2026-04-24	CSTL	24.47	45.7	-8.3	-1.17
2026-04-27	CSTL	24.99	45.7	-7.5	-1.17
2026-04-28	CSTL	24.69	45.7	-5.8	-1.17
2026-04-29	CSTL	24.27	45.7	-5.6	-1.17
2026-04-30	CSTL	24.47	45.7	-7.0	-1.17
2026-05-01	CSTL	24.87	45.7	-7.4	-1.17
2026-05-04	CSTL	25.52	45.7	-7.9	-1.17
2026-05-05	CSTL	24.61	45.7	-4.6	-1.17
2026-05-06	CSTL	24.75	45.7	-6.8	-1.17
2026-05-07	CSTL	19.22	45.7	5.9	-1.17
2026-05-08	CSTL	19.81	45.7	-20.2	-1.23
2026-05-11	CSTL	19.05	-310.5	-30.9	-1.23
2026-05-12	CSTL	18.68	-310.5	-32.5	-1.23
2026-05-13	CSTL	18.11	-310.5	-31.7	-1.23
2026-05-14	CSTL	18.88	-310.5	-37.7	-1.23
2026-05-15	CSTL	19.16	-310.5	-35.5	-1.27
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-15	CSTL	-27.37	-5.01	5.30
2026-04-17	CSTL	-27.37	-5.01	5.30
2026-04-20	CSTL	-27.37	-5.01	5.30
2026-04-21	CSTL	-27.37	-5.01	5.30
2026-04-22	CSTL	-27.37	-5.01	5.30
2026-04-23	CSTL	-27.19	-5.01	5.29
2026-04-24	CSTL	-29.19	-5.01	5.19
2026-04-27	CSTL	-29.19	-4.26	4.95
2026-04-28	CSTL	-29.19	-4.26	4.95
2026-04-29	CSTL	-29.19	-4.26	4.95
2026-04-30	CSTL	-29.19	-4.26	4.95
2026-05-01	CSTL	-29.19	-4.26	4.95
2026-05-04	CSTL	-29.28	-4.08	4.95
2026-05-05	CSTL	-28.39	-4.08	4.95
2026-05-06	CSTL	-28.39	-4.08	4.95
2026-05-07	CSTL	-27.72	-4.08	4.95
2026-05-08	CSTL	-27.72	-4.08	4.95
2026-05-11	CSTL	-27.70	-3.89	4.94
2026-05-12	CSTL	-28.40	-3.89	4.83
2026-05-13	CSTL	-28.40	-3.89	4.83
2026-05-14	CSTL	-26.59	-3.89	4.82
2026-05-15	CSTL	-27.01	-3.89	4.82
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.49

Avg. EPS Est. Current Quarter

-0.39

Avg. EPS Est. Next Quarter

-0.27

Insider Transactions

-27.01

Institutional Transactions

-3.89

Beta

1.04

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

19.47

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

75.7

Max Drawdown 5-Year %

-85

Target Price

45.88

P/E

Forward P/E

PEG

P/S

1.71

P/B

1.26

P/Free Cash Flow

128.37

EPS

-0.43

Average EPS Est. Cur. Y

-1.27

EPS Next Y. (Est.)

-0.81

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.78

Relative Volume

1.36

Return on Equity vs Sector %

-29.7

Return on Equity vs Industry %

-13.8

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.1

EBIT Estimation

-35.5

◆ CSTL Healthcare

$19.13

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

17/25

Volume

0/15

Valuation

15/20

TP/AR

2/10

Options

5/10

RSI

32.5

Range 1M

18.4%

Sup Dist

5.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

16/30

Estimates

2/20

Inst/Vol

3/15

Options

9/10

EPS Yr

-71.9%

EPS NY

36.8%

52W%

15.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +57% upside

Quality

6/30

Valuation

13/30

Growth

11/25

Stability

8/10

LT Trend

1/5

Upside

+57%

Quality

MoS

Castle Biosciences, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 942

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the likelihood of a positive sentinel lymph node and the risk of metastasis for patients with invasive cutaneous melanoma; TissueCypher, a risk stratification spatialomics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, and low-grade dysplasia BE; AdvanceAD-Tx, a non-invasive GEP test which is designed to guide systemic treatment selection for patients aged 12 years and older with moderateto-severe AD; DecisionDx-SCC, a GEP test for cutaneous squamous cell carcinoma; and MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions. It also provides DecisionDx-UM, a risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company offers its products to dermatology and gastroenterology markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.

CSTL

Latest News

—

Caricamento notizie per CSTL…

stock quote shares CSTL – Castle Biosciences Inc. Stock Price stock today

news today CSTL – Castle Biosciences Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CSTL – Castle Biosciences Inc. yahoo finance google finance

stock history CSTL – Castle Biosciences Inc. invest stock market

stock prices CSTL premarket after hours

ticker CSTL fair value insiders trading

RVTY – Revvity Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: RVTY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

XGN – Exagen Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: XGN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y